UnicoCell Biomed Announces Newly Elected Board of Directors (Including Independent Directors) at 2026 Annual General Meeting
On May 20, 2026, UnicoCell Biomed announced a full re-election of its Board of Directors following the expiration of the previous term. New board members, comprising corporate directors, individual directors, and independent directors, were elected at the Annual General Meeting. Tsai Yi-Wen was re-elected as Chairman, and Su Chun-Yuan was newly appointed as an independent director. The new term commenced on the same day.
📋 Article Processing Timeline
- 📰 Published: May 20, 2026 at 09:00
- 🔍 Collected: May 21, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 21, 2026 at 08:41 (41 min after Collected)
1. Date of change: 2026/05/20
2. Type of personnel change: Corporate Director, Independent Director, Natural Person Director
3. Name and title of former incumbents:
(1) Director: Tsai Yi-Wen
(2) Director: Chang Chia-Fang
(3) Director: JUNCHI BIOMEDICAL CO., LTD. Representative: Hsieh Hsiu-Mei
(4) Director: Ling Mei-Hua
(5) Director: SHIN YANG STEEL CO., LTD.
(6) Director: Chiu Yu-Cheng
(7) Independent Director: Shih Yaw-Tang
(8) Independent Director: Chen Cheng-Jen
(9) Independent Director: Lin Su-Lan
4. Brief resume of former incumbents:
(1) Director: Tsai Yi-Wen / Chairman of the Company
(2) Director: Chang Chia-Fang / Director of Nanya Printed Circuit Board Corp.
(3) Director: JUNCHI BIOMEDICAL CO., LTD. Rep: Hsieh Hsiu-Mei / Accountant at Gao Wei United CPAs Firm
(4) Director: Ling Mei-Hua / General Manager of TOAF-CHEN ENTERPRISE CO., LTD.
(5) Director: SHIN YANG STEEL CO., LTD. (Rep: Li Po-Huang / Chairman of Advanced Medical Technology Integration Development Committee, E-Da Healthcare Group)
(6) Director: Chiu Yu-Cheng / Presiding Lawyer at Chiu Yu-Cheng Law Office
(7) Independent Director: Shih Yaw-Tang / Chairman of the YAN YI Foundation
(8) Independent Director: Chen Cheng-Jen / Attending Physician & Director at Chiayi Christian Hospital
(9) Independent Director: Lin Su-Lan / Former AVP of Finance Department at Tao Miao Motor Co., Ltd.
5. Name and title of new incumbents:
(1) Director: Tsai Yi-Wen
(2) Director: Chang Chia-Fang
(3) Director: Qiteng Co., Ltd. Representative: Hsieh Hsiu-Mei
(4) Director: Ling Mei-Hua
(5) Director: SHIN YANG STEEL CO., LTD.
(6) Director: TAIFU BIOMEDICAL TECHNOLOGY CO., LTD.
(7) Independent Director: Su Chun-Yuan
(8) Independent Director: Chen Cheng-Jen
(9) Independent Director: Lin Su-Lan
6. Brief resume of new incumbents:
(1) Director: Tsai Yi-Wen / Chairman of the Company
(2) Director: Chang Chia-Fang / Director of Nanya Printed Circuit Board Corp.
(3) Director: Qiteng Co., Ltd. Rep: Hsieh Hsiu-Mei / Accountant at Gao Wei United CPAs Firm
(4) Director: Ling Mei-Hua / General Manager of TOAF-CHEN ENTERPRISE CO., LTD.
(5) Director: SHIN YANG STEEL CO., LTD. (Rep: Li Po-Huang / Chairman of Advanced Medical Technology Integration Development Committee, E-Da Healthcare Group)
(6) Director: TAIFU BIOMEDICAL TECHNOLOGY CO., LTD. (Rep: Chiu Yu-Cheng / Presiding Lawyer at Chiu Yu-Cheng Law Office)
(7) Independent Director: Su Chun-Yuan / Attending Physician, Department of Obstetrics and Gynecology, Taipei Mackay Memorial Hospital
(8) Independent Director: Chen Cheng-Jen / Vice Superintendent, Superintendent at Chiayi Christian Hospital
(9) Independent Director: Lin Su-Lan / Former AVP of Finance Department at Tao Miao Motor Co., Ltd.
7. Reason for the change: Term expired
8. Cause of change: Full re-election of the board.
9. Shareholding of new incumbents at the time of election:
(1) Director: Tsai Yi-Wen: 2,491,925 shares
(2) Director: Chang Chia-Fang: 0 shares
(3) Director: Qiteng Co., Ltd. Rep: Hsieh Hsiu-Mei: 9,899,000 shares
(4) Director: Ling Mei-Hua: 2,688,062 shares
(5) Director: SHIN YANG STEEL CO., LTD.: 8,000,000 shares
(6) Director: TAIFU BIOMEDICAL TECHNOLOGY CO., LTD.: 1,000 shares
(7) Independent Director: Su Chun-Yuan: 0 shares
(8) Independent Director: Chen Cheng-Jen: 0 shares
(9) Independent Director: Lin Su-Lan: 0 shares
10. Original term of office: 2023/06/30 to 2026/06/29
11. Effective date of new term: 2026/05/20
12. Percentage of directors changed during the same term: Not applicable due to full re-election.
13. Percentage of independent directors changed during the same term: Not applicable due to full re-election.
14. Percentage of supervisors changed during the same term: Not applicable.
15. Whether the change amounts to one-third or more of directors: No.
16. Other matters to be specified: None.
2. Type of personnel change: Corporate Director, Independent Director, Natural Person Director
3. Name and title of former incumbents:
(1) Director: Tsai Yi-Wen
(2) Director: Chang Chia-Fang
(3) Director: JUNCHI BIOMEDICAL CO., LTD. Representative: Hsieh Hsiu-Mei
(4) Director: Ling Mei-Hua
(5) Director: SHIN YANG STEEL CO., LTD.
(6) Director: Chiu Yu-Cheng
(7) Independent Director: Shih Yaw-Tang
(8) Independent Director: Chen Cheng-Jen
(9) Independent Director: Lin Su-Lan
4. Brief resume of former incumbents:
(1) Director: Tsai Yi-Wen / Chairman of the Company
(2) Director: Chang Chia-Fang / Director of Nanya Printed Circuit Board Corp.
(3) Director: JUNCHI BIOMEDICAL CO., LTD. Rep: Hsieh Hsiu-Mei / Accountant at Gao Wei United CPAs Firm
(4) Director: Ling Mei-Hua / General Manager of TOAF-CHEN ENTERPRISE CO., LTD.
(5) Director: SHIN YANG STEEL CO., LTD. (Rep: Li Po-Huang / Chairman of Advanced Medical Technology Integration Development Committee, E-Da Healthcare Group)
(6) Director: Chiu Yu-Cheng / Presiding Lawyer at Chiu Yu-Cheng Law Office
(7) Independent Director: Shih Yaw-Tang / Chairman of the YAN YI Foundation
(8) Independent Director: Chen Cheng-Jen / Attending Physician & Director at Chiayi Christian Hospital
(9) Independent Director: Lin Su-Lan / Former AVP of Finance Department at Tao Miao Motor Co., Ltd.
5. Name and title of new incumbents:
(1) Director: Tsai Yi-Wen
(2) Director: Chang Chia-Fang
(3) Director: Qiteng Co., Ltd. Representative: Hsieh Hsiu-Mei
(4) Director: Ling Mei-Hua
(5) Director: SHIN YANG STEEL CO., LTD.
(6) Director: TAIFU BIOMEDICAL TECHNOLOGY CO., LTD.
(7) Independent Director: Su Chun-Yuan
(8) Independent Director: Chen Cheng-Jen
(9) Independent Director: Lin Su-Lan
6. Brief resume of new incumbents:
(1) Director: Tsai Yi-Wen / Chairman of the Company
(2) Director: Chang Chia-Fang / Director of Nanya Printed Circuit Board Corp.
(3) Director: Qiteng Co., Ltd. Rep: Hsieh Hsiu-Mei / Accountant at Gao Wei United CPAs Firm
(4) Director: Ling Mei-Hua / General Manager of TOAF-CHEN ENTERPRISE CO., LTD.
(5) Director: SHIN YANG STEEL CO., LTD. (Rep: Li Po-Huang / Chairman of Advanced Medical Technology Integration Development Committee, E-Da Healthcare Group)
(6) Director: TAIFU BIOMEDICAL TECHNOLOGY CO., LTD. (Rep: Chiu Yu-Cheng / Presiding Lawyer at Chiu Yu-Cheng Law Office)
(7) Independent Director: Su Chun-Yuan / Attending Physician, Department of Obstetrics and Gynecology, Taipei Mackay Memorial Hospital
(8) Independent Director: Chen Cheng-Jen / Vice Superintendent, Superintendent at Chiayi Christian Hospital
(9) Independent Director: Lin Su-Lan / Former AVP of Finance Department at Tao Miao Motor Co., Ltd.
7. Reason for the change: Term expired
8. Cause of change: Full re-election of the board.
9. Shareholding of new incumbents at the time of election:
(1) Director: Tsai Yi-Wen: 2,491,925 shares
(2) Director: Chang Chia-Fang: 0 shares
(3) Director: Qiteng Co., Ltd. Rep: Hsieh Hsiu-Mei: 9,899,000 shares
(4) Director: Ling Mei-Hua: 2,688,062 shares
(5) Director: SHIN YANG STEEL CO., LTD.: 8,000,000 shares
(6) Director: TAIFU BIOMEDICAL TECHNOLOGY CO., LTD.: 1,000 shares
(7) Independent Director: Su Chun-Yuan: 0 shares
(8) Independent Director: Chen Cheng-Jen: 0 shares
(9) Independent Director: Lin Su-Lan: 0 shares
10. Original term of office: 2023/06/30 to 2026/06/29
11. Effective date of new term: 2026/05/20
12. Percentage of directors changed during the same term: Not applicable due to full re-election.
13. Percentage of independent directors changed during the same term: Not applicable due to full re-election.
14. Percentage of supervisors changed during the same term: Not applicable.
15. Whether the change amounts to one-third or more of directors: No.
16. Other matters to be specified: None.